459 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Bridge Advisory LLC

Bridge Advisory LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 459 shares of the healthcare conglomerate’s stock, valued at approximately $236,000.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter worth $4,478,185,000. Arrowstreet Capital Limited Partnership grew its stake in shares of UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of UnitedHealth Group by 60.4% during the 1st quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock worth $2,580,442,000 after acquiring an additional 1,886,128 shares during the period. Capital Research Global Investors lifted its holdings in UnitedHealth Group by 8.3% during the 1st quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock worth $9,829,129,000 after purchasing an additional 1,482,338 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in UnitedHealth Group by 28.3% during the 1st quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock worth $3,069,002,000 after purchasing an additional 1,328,237 shares in the last quarter. Institutional investors own 87.25% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. UBS Group increased their price objective on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a report on Thursday, July 21st. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a report on Thursday, September 8th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. SVB Leerink raised their price target on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Finally, Credit Suisse Group raised their price target on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $586.40.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 139,051 shares of company stock worth $74,450,958. 0.40% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $517.46 on Friday. The stock’s 50 day simple moving average is $530.11 and its 200 day simple moving average is $512.45. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The firm has a market cap of $484.02 billion, a price-to-earnings ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period last year, the company earned $4.70 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were given a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.